Tranexamic Acid offered by COSROMA is called Cosroma® TAA. Cosroma® TAA is 98% Tranexamic Acid. Tranexamic Acid is an internationally recognized skin whitening ingredient. Tranexamic Acid can prevent Melanin synthesis by inhibiting the key transcription factors of MITF, thus eliminating or reducing Chloasma (Chloasma is a disease caused by metabolic disorder of skin pigment) from the root.
| Name (CAS Number) | |
|---|---|
| Tranexamic acid (1197-18-8) | Sign in to view |
The following lists represent a selection of UL's ChemADVISOR™ Regulatory Database, curated for Prospector in Compliance Highlights. Need more context for understanding these highlights? We recommend UL's Navigator, your gateway to regulatory compliance (free trial available).
| Name (CAS Number) | |
|---|---|
|
Tranexamic acid (1197-18-8)
|
Sign in to view |
| General | |||
|---|---|---|---|
| Appearance | Sign in to view | ||
| Color | Sign in to view | ||
| Use Level | Sign in to view | ||
COSROMA® is a China-based manufacturer and supplier specialized in cosmetic and personal care ingredients. COSROMA® has passed ISO9001, ISO45001 and IS014001 certification, and owes certificates of COSMOS, KOSHER, HALAL, REACH, etc.
Relying on 3 R&D centers, 5 production bases and the powerful industry resource integration capabilities, COSROMA® is offering a rich product portfolio including actives, surfactants, thickeners, conditioners, emulsifiers, preservatives, herbal extracts, plant essential oils, flavors and fragrance, etc.
COSROMA®'s excellent R&D capabilities also enable us to provide customized product development and manufacturing services, particularly in the areas of small molecule synthesis and plant extraction.
COSROMA® has established a stable distribution network in about 20 countries and regions around the world, which can provide timely and high-quality localized services for most customers.
The information presented here was acquired by UL from the producer of the product or material or original information provider. However, UL assumes no responsibility or liability for the accuracy of the information contained on this website and strongly encourages that upon final product or material selection information is validated with the manufacturer. This website provides links to other websites owned by third parties. The content of such third party sites is not within our control, and we cannot and will not take responsibility for the information or content.
COSROMA makes their documentation available in the regions indicated below:
The following lists represent a selection of UL's ChemADVISOR™ Regulatory Database, curated for Prospector in Compliance Highlights. Need more context for understanding these highlights? We recommend UL's Navigator, your gateway to regulatory compliance (free trial available).
With a Premium Prospector account, view regulatory advisory and retailer compliance on an ingredients level for your material searches. The full set of lists reviewed have been curated by UL's LOLI Regulatory Database specific for Prospector. Upgrade today!
Lists combine the ease of Bookmarks with the versatility of Tags. Instead of one collection of bookmarked items, create as many collections, called "Lists," as you need.
Find the link to your List page in the user menu.
All Tags have been converted to separate Lists, and your bookmarked items have been saved to a "Bookmarks" List.
When you click the Add to List button, a dropdown of your existing Lists appears. Click the List name to which you want to add this product or formula.
You can also create a new List. Simply click "Create a New List" and enter a name.
When you define a new List, the current item is automatically added to it. You can add a product or formula to as many Lists as you need.
Easily see which Lists this item appears in, and quickly go to that List from the links that appear on the page.
We're sorry, but the industry you have selected is not currently available in your chosen language. You may choose a language below to continue to this industry or close this dialog above.
GDPR Notice: